Floatz logo

Encorafenib

Melanoma and Metastatic Colorectal Cancer

PfizerSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Melanoma and Metastatic Colorectal Cancer cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Encorafenib is also rated in:

colon carcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colon adenocarcinomaDormant
BB
Indicative ·
67 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →